Trinity biotech Captia (TM) Syphilis IgM Capture Test Kit, Product No./REF 800-935, Test Kit for 96 Determinations, IVD for In Vitro Diagnostic use; an antibody class capture enzyme immunoassay for the detection of IgM antibodies to T. pallidum as an aid to the identification of active syphilis in human serum.
Published December 24, 2014 · Recall initiated: November 17, 2014
Summary
FDA records medical device Class III recall Z-0819-2015, published December 24, 2014 and initiated November 17, 2014. Recalling firm: Clark Laboratories, Inc. (dba,Trinity Biotech USA); Status: Terminated; Reported quantity: Domestic: 9 kits; Foreign: 26 kits; Lot: Lot 033, expiry date 30 November 2014. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Through in-house routine real time stability monitoring of Trinity's Captia Syphilis IgM Capture Test Kit, Lot 033, the firm identified a failure of the kit to meet its labeled expiry dating of 6 months.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Clark Laboratories, Inc. (dba,Trinity Biotech USA)
- Distributor
- New York, Florida, Utah, and California plus foreign distribution to Spain and France
- Lot
- Lot 033, expiry date 30 November 2014
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquidDecember 26, 2018
- FDAQ-Station Quantification Software. Q-Station 3.0 with a2DQ and/or aCMQ Q-Apps are affected. Model: Q-Station,December 24, 2014
- FDACARESTREAM DIRECTVIEW CR Software Generates digital mammographic images that can be used for screening andDecember 24, 2014
- FDAEPIQ 7 Ultrasound System, EPIQ 7 systems with software versions 1.0.x or 1.1.x with QLAB a2DQ and/or aCMQDecember 24, 2014
- FDACaptia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgGJanuary 1, 2014
- FDATrinity Biotech, Captia VZV IgG. Product code 2325600: 96 Tests; product code: 2325601: 480 tests. For inOctober 3, 2012
Questions about this recall
Was Trinity biotech Captia (TM) Syphilis IgM Capture Test Kit, Product No./REF 800-935, Test Kit for 96 Determinations, IVD for In Vitro Diagnostic use; an antibody class capture enzyme immunoassay for the detection of IgM antibodies to T. pallidum as an aid to the identification of active syphilis in human serum. recalled?
Yes. FDA published recall Z-0819-2015 on December 24, 2014. Reported hazard: Through in-house routine real time stability monitoring of Trinity's Captia Syphilis IgM Capture Test Kit, Lot 033, the firm identified a failure of the kit to meet its labeled expiry dating of 6 months.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail